Skip to main content
Skip to section navigation
Skip to footer
ViraxImmune™
Products
Services
Media
Leadership
Contact Us
Investor Relations
Menu
ViraxImmune™
Products
Services
Media
Leadership
Contact Us
Investor Relations
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Board Diversity Matrix
Annual Reports
Filing Type:
View All
20-F
NT 20-F
Year:
View All
2024
2023
2022
2021
Date
Form
Description
PDF
XBRL
Pages
08/20/24
20-F
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
Documents
expand_more
EX-8.1
EX-12.1
EX-12.2
EX-13.1
EX-13.2
115
08/01/24
NT 20-F
Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F
6
06/14/23
20-F
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
Documents
expand_more
EX-8.1
EX-10.10
EX-10.11
EX-12.1
EX-12.2
EX-13.1
EX-13.2
173
08/12/22
20-F
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
Documents
expand_more
EX-12.1
EX-12.2
EX-13.1
EX-13.2
133
07/29/22
NT 20-F
Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F
4
rss_feed
Filing RSS
Email Alerts
Contacts
RSS News Feed